121 related articles for article (PubMed ID: 10191194)
1. Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: no detection of reactivation after stimulation with a recall antigen.
Sernicola L; Corrias F; Koanga-Mogtomo ML; Baroncelli S; Di Fabio S; Maggiorella MT; Belli R; Michelini Z; Macchia I; Cesolini A; Cioè L; Verani P; Titti F
Virology; 1999 Apr; 256(2):291-302. PubMed ID: 10191194
[TBL] [Abstract][Full Text] [Related]
2. Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus.
Norley S; Beer B; Binninger-Schinzel D; Cosma C; Kurth R
Virology; 1996 May; 219(1):195-205. PubMed ID: 8623530
[TBL] [Abstract][Full Text] [Related]
3. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys.
Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F
Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys.
Titti F; Sernicola L; Geraci A; Panzini G; Di Fabio S; Belli R; Monardo F; Borsetti A; Maggiorella MT; Koanga-Mogtomo M; Corrias F; Zamarchi R; Amadori A; Chieco-Bianchi L; Verani P
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2529-39. PubMed ID: 9349474
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
[TBL] [Abstract][Full Text] [Related]
6. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
[TBL] [Abstract][Full Text] [Related]
7. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.
Stahl-Hennig C; Dittmer U; Nisslein T; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Mätz-Rensing K; Kuhn EM; Kaup FJ; Rud EW; Hunsmann G
J Gen Virol; 1996 Dec; 77 ( Pt 12)():2969-81. PubMed ID: 9000087
[TBL] [Abstract][Full Text] [Related]
8. Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion.
Stahl-Hennig C; Dittmer U; Nisslein T; Pekrun K; Petry H; Jurkiewicz E; Fuchs D; Wachter H; Rud EW; Hunsmann G
Immunol Lett; 1996 Jun; 51(1-2):129-35. PubMed ID: 8811357
[TBL] [Abstract][Full Text] [Related]
9. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
Heeney JL; de Vries P; Dubbes R; Koornstra W; Niphuis H; ten Haaft P; Boes J; Dings ME; Morein B; Osterhaus AD
J Med Primatol; 1992; 21(2-3):126-30. PubMed ID: 1433263
[TBL] [Abstract][Full Text] [Related]
10. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.
Michelini Z; Negri DR; Baroncelli S; Catone S; Comini A; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Rovetto C; Liljestrom P; Norley S; Heeney J; Titti F
J Med Primatol; 2004 Oct; 33(5-6):251-61. PubMed ID: 15525326
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection.
Stebbings R; Berry N; Stott J; Hull R; Walker B; Lines J; Elsley W; Brown S; Wade-Evans A; Davis G; Cowie J; Sethi M; Almond N
Virology; 2004 Dec; 330(1):249-60. PubMed ID: 15527850
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of protection induced by attenuated simian immunodeficiency virus.
Stebbings RJ; Almond NM; Stott EJ; Berry N; Wade-Evans AM; Hull R; Lines J; Silvera P; Sangster R; Corcoran T; Rose J; Walker KB
Virology; 2002 May; 296(2):338-53. PubMed ID: 12069532
[TBL] [Abstract][Full Text] [Related]
13. A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge.
Putkonen P; Thorstensson R; Cranage M; Nilsson C; Ghavamzadeh L; Albert J; Greenaway P; Biberfeld G
J Med Primatol; 1992; 21(2-3):108-12. PubMed ID: 1433260
[TBL] [Abstract][Full Text] [Related]
14. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
15. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
16. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
[TBL] [Abstract][Full Text] [Related]
17. Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge.
Heeney JL; Holterman L; ten Haaft P; Dubbes R; Koornstra W; Teeuwsen V; Bourquin P; Norley S; Niphuis H
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S117-21. PubMed ID: 7865285
[TBL] [Abstract][Full Text] [Related]
18. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.
Nixon DF; Donahoe SM; Kakimoto WM; Samuel RV; Metzner KJ; Gettie A; Hanke T; Marx PA; Connor RI
Virology; 2000 Jan; 266(1):203-10. PubMed ID: 10612675
[TBL] [Abstract][Full Text] [Related]
19. Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.
Khatissian E; Monceaux V; Cumont MC; Kieny MP; Aubertin AM; Hurtrel B
J Virol; 2001 Feb; 75(3):1507-15. PubMed ID: 11152522
[TBL] [Abstract][Full Text] [Related]
20. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
